BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33983643)

  • 1. Aberrant expression of LncRNA CASC2 mediated the cell viability, apoptosis and autophagy of colon cancer cells by sponging miR-19a via NF-κB signaling pathway.
    Zhang P; Pan Y; Sun J; Pan G
    Int J Exp Pathol; 2021 Jun; 102(3):163-171. PubMed ID: 33983643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a.
    Li Y; Lv S; Ning H; Li K; Zhou X; Xv H; Wen H
    Biomed Pharmacother; 2018 Dec; 108():1775-1782. PubMed ID: 30372881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA cancer susceptibility candidate 2 regulates the function of human fibroblast-like synoviocytes via the microRNA-18a-5p/B-cell translocation gene 3 signaling axis in rheumatoid arthritis.
    Ye Z; Wei L; Yin X; Li H; Qin G; Li S; Peng T; Liu B; Zhao S; Zhuo Q
    Bioengineered; 2022 Feb; 13(2):3240-3250. PubMed ID: 35045800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression.
    Jiang C; Shen F; Du J; Fang X; Li X; Su J; Wang X; Huang X; Liu Z
    Biomed Pharmacother; 2018 Jan; 97():844-850. PubMed ID: 29136760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU-Binding Factor 1 (AUF1)/B-Cell CLL/Lymphoma 2 (Bcl-2) Axis.
    Dai W; Mu L; Cui Y; Li Y; Chen P; Xie H; Wang X
    Med Sci Monit; 2019 Jan; 25():730-738. PubMed ID: 30681073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA CASC2 targeting miR-18a suppresses glioblastoma cell growth, metastasis and EMT
    Wang J; Qin C; Zhong C; Wen Y; Ke S; Liao BO
    J Biosci; 2020; 45():. PubMed ID: 32975234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA CASC2 regulates hepatocellular carcinoma cell oncogenesis through miR-362-5p/Nf-κB axis.
    Zhao L; Zhang Y; Zhang Y
    J Cell Physiol; 2018 Oct; 233(10):6661-6670. PubMed ID: 29319182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
    Xiao XH; He SY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA CASC2 inhibits tumorigenesis via the miR-181a/PLXNC1 axis in melanoma.
    Wang Z; Wang X; Zhou H; Dan X; Jiang L; Wu Y
    Acta Biochim Biophys Sin (Shanghai); 2018 Mar; 50(3):263-272. PubMed ID: 29514220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated lncRNA CASC2 May Inhibit Malignant Melanoma Development Through Regulating miR-18a-5p/RUNX1.
    Zhang Y; Qian W; Feng F; Cao Q; Li Y; Hou Y; Zhang L; Fan J
    Oncol Res; 2019 Feb; 27(3):371-377. PubMed ID: 29422114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway.
    Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L
    Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA CASC2 inhibits autophagy and promotes apoptosis in non-small cell lung cancer cells
    Li Q; Chen K; Dong R; Lu H
    RSC Adv; 2018 Dec; 8(71):40846-40855. PubMed ID: 35557905
    [No Abstract]   [Full Text] [Related]  

  • 13. Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21.
    Wang P; Liu YH; Yao YL; Li Z; Li ZQ; Ma J; Xue YX
    Cell Signal; 2015 Feb; 27(2):275-82. PubMed ID: 25446261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA CASC2 inhibits lipopolysaccharide‑induced acute lung injury via miR‑27b/TAB2 axis.
    Li X; Mo J; Li J; Chen Y
    Mol Med Rep; 2020 Dec; 22(6):5181-5190. PubMed ID: 33174006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB maintains the stemness of colon cancer cells by downregulating miR-195-5p/497-5p and upregulating MCM2.
    Wang L; Guo J; Zhou J; Wang D; Kang X; Zhou L
    J Exp Clin Cancer Res; 2020 Oct; 39(1):225. PubMed ID: 33109220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in
    Inoue A; Mizushima T; Wu X; Okuzaki D; Kambara N; Ishikawa S; Wang J; Qian Y; Hirose H; Yokoyama Y; Ikeshima R; Hiraki M; Miyoshi N; Takahashi H; Haraguchi N; Hata T; Matsuda C; Doki Y; Mori M; Yamamoto H
    Mol Cancer Ther; 2018 May; 17(5):977-987. PubMed ID: 29545333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network.
    Wang BD; Kline CL; Pastor DM; Olson TL; Frank B; Luu T; Sharma AK; Robertson G; Weirauch MT; Patierno SR; Stuart JM; Irby RB; Lee NH
    Mol Cancer; 2010 Apr; 9():98. PubMed ID: 20433755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG16 promoted proliferation and inflammatory response of macrophages through miR-17-5p/NF-κB signaling pathway in patients with atherosclerosis.
    An JH; Chen ZY; Ma QL; Wang HJ; Zhang JQ; Shi FW
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8665-8677. PubMed ID: 31646601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
    Sun J; Liu L; Zou H; Yu W
    Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA CASC2 Alleviates the Progression of Diabetic Nephropathy by Regulating the miR-144/SOCS2 Signalling Axis.
    Min XQ; Xie Y
    Kidney Blood Press Res; 2020; 45(6):837-849. PubMed ID: 33227790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.